| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 76,549 | 75,466 | ||
| Restricted cash | 261 | 259 | ||
| Short-term marketable securities | 0 | 8,759 | ||
| Accounts receivable, net | 13,797 | 15,903 | ||
| Inventory | 16,248 | 16,175 | ||
| Prepaid expenses and other current assets | 4,380 | 3,458 | ||
| Total current assets | 111,235 | 120,020 | ||
| Long-term inventory | 2,474 | 1,892 | ||
| Property and equipment, net | 2,443 | 2,660 | ||
| Goodwill | 2,333 | 2,333 | ||
| Right of use assets | 18,279 | 18,643 | ||
| Other long-term assets | 1,517 | 1,639 | ||
| Total assets | 138,281 | 147,187 | ||
| Accounts payable | 6,420 | 6,557 | ||
| Accrued liabilities | 14,936 | 14,388 | ||
| Income taxes payable | 189 | 205 | ||
| Deferred revenue | 92 | 78 | ||
| Short-term debt | 105 | 104 | ||
| Current lease liabilities | 1,136 | 1,115 | ||
| Total current liabilities | 22,878 | 22,447 | ||
| Deferred tax liability | 47 | 41 | ||
| Long-term lease liabilities | 18,298 | 18,598 | ||
| Long-term debt | 37,025 | 37,011 | ||
| Total liabilities | 78,248 | 78,097 | ||
| Common stock, 0.001 par value, 200,000,000 shares authorized as of september30, 2025 and december31, 2024 41,246,534 shares issued and outstanding as of september30, 2025 and 39,785,969 shares issued and outstanding as of december31, 2024 | 41 | 41 | ||
| Additional paid-in capital | 568,887 | 563,589 | ||
| Accumulated other comprehensive income | 2,238 | 2,636 | ||
| Accumulated deficit | -511,133 | -497,176 | ||
| Total stockholders equity | 60,033 | 69,090 | ||
| Total liabilities and stockholders equity | 138,281 | 147,187 | ||
Pulmonx Corp (LUNG)
Pulmonx Corp (LUNG)